Error message

Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in theme_biblio_custom() (line 367 of /home/phcogcommn/

Antidiabetic Effect of Memecylon Talbotianum Leaf Methanol Active Fraction in Male Wistar Rats


Pharmacognosy Communications,,2017,7,3,114-120.
Published:September 2017
Type:Original Article

Antidiabetic Effect of Memecylon Talbotianum Leaf Methanol Active Fraction in Male Wistar Rats

Bharathi T.R., Noor Mohamed Jameel, Behrouz Jalali Ghassam, Shrisha Naik Bajpe, Prakash HS*

Department of Studies in Biotechnology, University of Mysore, Manasagangotri, Mysore, INDIA.


Introduction: Memecylon talbotianum Brandis, (Melastomataceae) is an indigenous medicinal plant used in ethno-medicine including Ayurveda. However, the potential of this plant in controlling diabetes has not yet been evaluated. The role of M. talbotianum leaf extract on streptozotocin (STZ, 2-deoxy-2-(3- (methyl-3-nitrosoureido) d-glucopyranose- induced diabetes in male Wistar rats is investigated. Methods: The leaf extract was fractionated, its phytoconstituents were evaluated using HPLC and rats (6 animals in each group) were treated orally with M. talbotianum leaf methanol active fraction (MTLMAF) (100, 200 and 1000 mg/kg body weight) for 28 days with a single dose with metformin as a positive control. Biochemical parameters, histopathological and immunostaining studies were performed. Results: Administration of MTLMAF, significantly decreased the glucose level after four weeks (312 ± 14 mg/dL in diabetic animals compared to 134 ± 13 mg/dL in MTLMAF treated animals) and controlled the levels of TG (155 ± 63.55 units/dL in diabetic and 100.66 ± 13.31 units/dL in treated animals), LDL, HDL, VLDL and endogenous antioxidants (SOD, catalase and GSH). Histopathological studies substantiated the protective role of MTLMAF. MTLMAF also alleviated liver and pancreatic damage in STZdiabetic rats. HPLC analysis revealed that rutin, quercetin and protocatechuic acid were the major components present in M. talbotianum. The presence of these compounds in M. talbotianum is reported for the first time here and these compounds may be responsible for antidiabetic properties. Conclusion: Our study shows that MTLMAF could protect rats against streptozotocin induced diabetes, improves lipid profile, reduce the risk of oxidative stress and, ameliorate liver and pancreatic damage.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.